Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIRA: BCD-055 vs Remicade in Active Rheumatoid Arthritis
NCT02762838Phase 3Completed
- Sponsor
- BIOCAD
- Start
- Jan 2016
- Primary completion
- Jul 2018
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 3 trial of Zessly in rheumatoid arthritis (RA), sponsored by BIOCAD. Started Jan 2016; status: completed.
02
Drugs
Zessly
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02762838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02762838.